Miltenyi Bioindustry
Bergisch Gladbach, Germany miltenyibioindustry.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Miltenyi Bioindustry is a CDMO for cell and gene therapy products and lentiviral vectors. It supports clients from pre-clinical development through clinical and commercial manufacturing in Europe, North America, and Asia.
Services
Cell and gene therapy services
Supports cell and gene therapy programs from program scope development and assay development through clinical and GMP-compliant manufacturing.
Engineered T cell manufacturing
Provides automated manufacturing workflows for engineered T cells on the CliniMACS Prodigy Platform, including viral and non-viral engineering approaches.
Engineered NK cell manufacturing
Provides automated manufacturing workflows for engineered NK cells, including CAR NK cell transduction and scale-up support.
Lentiviral vector services
Offers lentiviral vector design, optimization, preclinical production, clinical production, and commercial manufacturing across scales.
Regulatory support services
Provides quality and regulatory support for cell therapy and lentiviral vector programs from pre-IND through marketing authorization.
- Turnaround
- Get to clinical trials in as little as 9 months
- From preclinical to GMP lentiviral vector in as little as 8.5 months
- What to send
- Starting materials such as leukapheresis, bone marrow, peripheral blood, cord blood, or tumor tissue
- Plasmid designs for lentiviral vector evaluation
Capabilities
- Assays and studies
- Lentivirus
- Cell therapy
- Flow cytometry
- Analytical development
- Potency assays
- Killing assay
9 more
- Cytokine secretion assay
- Vector copy number determination
- RCL determination
- Cell quantification
- Cell characterization
- Analytical assay development
- Identity assays
- Purity assays
- Safety tests
- Scale and capacity
- Over 900 GMP cell therapy batches manufactured
- Over 350 GMP lentiviral vector batches manufactured
- Support over 100 clinical trials
- Manufacturing sites on three continents
- Preclinical to commercial scale
- 4 L to 200 L lentiviral vector production
- Therapeutic areas
- Immunotherapy
- Regenerative medicine
- Graft engineering
Modalities and species
- Modalities
- mRNA
- Viral vector
- Cell therapy
- Gene editing
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 13485Self-reported
Scope: MACS GMP Products
GMPSelf-reported
Scope: cell therapy and lentiviral vector manufacturing
Details
- Type
- CDMO
- Based in
- Bergisch Gladbach, Germany
- Sites
- San Jose, United States
- Gaithersburg, United States
- Shanghai, China
- Teterow, Germany
- Serves
- Worldwide, 30+ countries, 45 countries